Israel Englander Seagen Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $168 Million - $184 Million	893,994 Added 120.88%	1,633,535 $314 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $91.5 Million - $146 Million	717,519 Added 3258.19%	739,541 $150 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $7.48 Million - $8.87 Million	-63,732 Reduced 74.32%	22,022 $2.83 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $76.8 Million - $102 Million	-567,816 Reduced 86.88%	85,754 $11.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.